Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Neill, S.
Right arrow Articles by Watson, R. W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Neill, S.
Right arrow Articles by Watson, R. W. G.
(Journal of Leukocyte Biology. 2000;68:15-20.)
© 2000 by Society for Leukocyte Biology

Altered caspase expression results in delayed neutrophil apoptosis in acute pancreatitis

Sean O’Neill, Amanda J. O’Neill, Eimear Conroy, Hugh R. Brady*, John. M. Fitzpatrick and R. William G. Watson

Department of Surgery and
* Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin and Mater Misericordiae Hospital, Dublin 7, Ireland


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Acute pancreatitis (AP) may lead to the development of multiple organ dysfunction syndrome (MODS), especially in severe cases. Resolution of such inflammatory responses is dependent on neutrophil apoptosis. Delays in this apoptotic response are associated with persistent inflammation and subsequent tissue damage. The aim of this study is to determine the effects of AP on neutrophil apoptosis and to investigate the underlying mechanisms involved. Neutrophils and serum were isolated from control (n=10) and from patients with AP (mild, n=35, and severe, n=5). Neutrophil apoptosis was assessed by propidium iodide DNA staining using flow cytometry. Caspase, glutathione-S-transferase (GST), and Mcl-1 protein expression were assessed by SDS-PAGE western blotting. Serum interleukin (IL)-1ß and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels were measured by ELISA. Neutrophils isolated from patients with AP show a significant delay in spontaneous neutrophil apoptosis. Serum factors contributed to this delay with increases in IL-1ß and GM-CSF. Isolated neutrophils were resistant to Fas antibody-induced apoptosis. Caspases represent a central mechanism for spontaneous and Fas antibody-induced neutrophil apoptosis. Procaspase 3 expression was decreased in mild and severe cases, but this effect was independent of serum factors. Increases in GST expression may also contribute to the antiapoptotic effect. Altered caspase expression may represent an additional factor contributing to delayed neutrophil apoptosis. This may contribute to the development of AP and its related complications.

Key Words: acute pancreatitis • caspases • Fas


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Acute pancreatitis (AP) is an acute inflammatory process of the pancreas with variable involvement of other regional tissues or remote organ systems [1 ]. It has multiple aetiology, although gallstones and alcohol are precipitating factors in the majority of cases. Usually, mild AP results in an oedematous pancreatitis and is associated with minimal organ dysfunction and an uneventful recovery. By contrast and by definition, severe AP is associated with the development of organ failure [including multiple organ dysfunction syndrome (MODS)] and/or local complications, such as necrosis, pseudocyst, or abscess formation [2 ]. Most often, severe AP is an expression of pancreatic necrosis, which is associated with an increased mortality risk. Currently, about one-third of patients die in the early phase of an AP attack from multiple organ failure [3 ].

Neutrophils play an important role in the development of many inflammatory disorders [4 ]. Their release of reactive oxygen intermediates and proteolytic enzymes is associated with extensive tissue damage, specifically necrosis [5 ]. In animal models of AP, the neutrophil has been implicated in the destruction of the pancreas and the development of acute lung injury associated with this condition [2 , 6 , 7 ]. The resolution of any neutrophil-mediated inflammatory response is, in part, because of the induction of neutrophil apoptosis, resulting in the disposal of these cells in a controlled process [8 ]. Delayed apoptosis is associated with the development and persistence of inflammatory disorders, including inflammatory bowel disease (unpublished results), acute respiratory distress syndrome (ARDS) [9 ], and systemic inflammatory response syndrome (SIRS) [10 ].

The life span and functional activity of the neutrophil can be extended significantly by the inflammatory microenvironment. Proinflammatory cytokines, cell migration, and neutrophil states of activation mediate survival [11 12 13 ]. However, the mechanisms of this delay are still unknown. Caspase proteases are central executioners of the cell death pathway [14 , 15 ]. Freshly isolated neutrophils have a high expression of procaspase 3 [16 ], which is cleaved during spontaneous apoptosis. Spontaneous and induced neutrophil apoptosis results in caspase activation, which is inhibited by preincubation with inflammatory mediators [17 ].

We hypothesized that neutrophils isolated from patients with AP have a delay in neutrophil apoptosis, which is regulated by altered caspase expression. This may contribute to the persistence and severity of the response.

In this study, delayed neutrophil apoptosis was associated with mild and, to a greater degree, severe AP. Isolated neutrophils were resistant to Fas antibody-inducted apoptosis. This resistance may be explained by altered procaspase 3 expression, but no change in the initiator procaspase 8 was shown. Serum factors were shown to regulate apoptosis of which interleukin (IL)-1ß and granuloctye-macrophage colony-stimulating factor (GM-CSF) were elevated. These effects were independent of altered procaspase 3 expression. Altered apoptosis and procaspase 3 expression in patient neutrophils were associated with an increase in glutathione-S-transferase (GST), an important regulator of glutathione that has antiapoptotic effects. There was no increase in Mcl-1, which is a member of the Bcl-2 family of antiapoptotic proteins. Alterations in the caspase cascade may represent an additional site contributing to delayed apoptosis.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Patient group
The study population consisted of hospital inpatients and patients (admitted via the accident and emergency department of the Mater Misericordiae Hospital, Dublin, Ireland) with AP between June 1998 and February 1999. A diagnosis of AP was established on the basis of clinical history and examination, hyperamylasaemia (>3 times the upper limit of normal), and the absence of other acute pathology. Ultrasound and/or computed tomography were used to visualize the pancreas in all cases. Imrie’s Glasgow scoring system was employed to predict outcome, and development of complications, including single or multiple organ failure or death secondary to acute pancreatitits, was observed. Ultimately patients were defined as having mild or severe AP depending on their clinical course and outcome. The study protocol was reviewed and approved by the Mater Misericordiae Hospital ethics committee, and written consent was obtained from all patients or a surrogate.

We studied 10 healthy controls with a mean age of 45 (range, 24–66) with a male:female ratio of 5:5, and 40 patients with AP. This group was divided into mild (n=35), with a mean age of 44 (range, 16–93) and a male:female ratio of 1:1, and severe (n=5), with a mean age of 49 (range, 26–70) and a male:female ratio of 4:1.

Only patients with AP who had developed symptoms (predominantly pain) in the preceding 24 h were enrolled in the study. Systemic venous blood (10 ml) was collected following diagnosis, before the institution of any medical treatment. This was immediately transported to the laboratory, where serum and neutrophils were isolated for analysis. No further blood samples were obtained from the patients.

Reagents and antibodies
Dulbecco’s modified Eagle’s medium (DMEM), penicillin and streptomycin solution, L-glutamine, and fetal calf serum (FCS) were purchased from GIBCO Life Technologies (Paisley, UK). Dextran T-500 and Ficoll were purchased from Pharmacia (Buckinghamshire, UK). E-lysis was purchased from Cardinal Associates (Santa Fe, NM). Procaspase 3 and 8 antibodies (mouse antihuman), as well as anti-GST and Mcl-1 antibodies (mouse antihuman), were purchased from Transduction Laboratories (Lexington, KY), and Fas antibody (CH-11) was from Immunotech (Bedfordshire, UK). Blocking monoclonal antibodies (mAbs) to IL-1ß and GM-CSF were purchased from R&D Systems (Oxon, UK). All remaining chemicals were purchased from Sigma-Aldrich Company (Dorset, UK), if not otherwise stated.

Neutrophil isolation
Neutrophils were isolated by dextran (6%) sedimentation and centrifugation through a discontinuous Ficoll gradient, as described previously [18 ]. Neutrophil-rich pellets were subjected to hypotonic lysis of the remaining erythrocytes with E-lysis. Cell pellets were resuspended in DMEM, supplemented with 10% FCS (heat inactivated), 1% glutamine, and 1% penicillin/streptomycin solution at a concentration of 1 x 106 cells/ml. Cells were incubated in polypropylene tubes (Falcon/Becton Dickinson, Cambridge, UK) to prevent adherence. Neutrophil purity was 95%, as assessed by size and granularity on flow cytometry, and viability was >98%, as assessed by trypan blue and propidium iodide exclusion.

Quantification of apoptosis
Propidium iodide DNA staining
Apoptosis was measured by flow cytometry as the percentage of cells with hypodiploid DNA [18 ]. Cell suspensions were centrifuged at 200 g for 10 min. The cell pellets were resuspended in 500 µl of hypotonic fluorochrome solution [50 µg/ml phosphatidylinositol (PI), 3.4 mM sodium citrate, 1 mM ethylenediaminetetraacetate (EDTA), 0.1% Triton X-100] and were stored in the dark at 4°C before they were analyzed using a Coulter Elite cytofluorometer (Coulter, Bedfordshire, UK).

Annexin-V
The expression of phosphatidylserine on the surface of apoptotic cell was assessed by fluorescein isothiocyanate (FITC) Annexin-V antibody, detected using flow cytometry. Cell suspensions were washed with cold phosphate-buffered saline (PBS), resuspended at 1 x 104/100 µl, and stained according to the manufacturer’s specifications. After staining, cells were stored in the dark at 4°C before they were analyzed using a Coulter Elite cytofluorometer (Coulter).

Morphology
Cells were resuspended to 1 x 106/200 µl, spun onto polysine slides using a cytospin (Shandon, Chestire, UK) at 500 g for 5 min, and stained with Giemsa stain. Apoptotic cells were identified by nuclear condensation at 40x magnification.

Western blot analysis
Total protein was isolated from 2 x 106 human neutrophils using Nonidet P-40 (NP-40) isolation solution [0.5% NP-40, 10 mM Tris, pH 8.0, 60 mM KCl, 1 mM EDTA, pH 8.0, 1 mM dithiothreitol (DTT), 10 mM phenylmethylsulfonyl fluoride (PMSF), and 1 µM leupeptin and aprotinin]. Isolated protein concentrations were measured by the Bradford assay Protein Detection Kit (Bio-Rad, Hercules, CA) and were loaded at 50 µg per well. Samples were then run on 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gradient gel (140 V for 60 min) and were electrophoretically transferred to Immobilon-P (Millipore, Bedford, MA) (100 V, 45 min). Membranes were stained after transfer with ponceau S solution (2%) to confirm equal loading. Blots were incubated with mouse antiprocaspase 3 primary antibody (1:1000) in 1% bovine serum albumin (BSA) Tris-buffered solution and 0.1% Tween 20 for 1 h at room temperature and were then incubated with horseradish peroxidase (HRP)-conjugated antimouse immunoglobulin G (IgG) at 1:5000 dilution for 1 h. Blots were developed using an enhanced chemiluminescence (ECL) system.

Serum IL-1ß and GM-CSF concentration
Standard enzyme-linked immunosorbent assay (ELISA) technique (R&D Quantikine, R&D Systems) was used to measure IL-1ß and GM-CSF in serum isolated from the systemic circulation of control patients and those with AP. Blood was collected and transported on ice. Serum was separated within 1 h of collection and stored at -80°C. All samples were analyzed within 3 months of collection.

Statistics
Statistical analysis was carried out using analysis of variance (ANOVA) with Student-Newman correction. All results are expressed as mean ± standard deviation (SD). Significance was assumed for values of P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Patient demographics
Of the 40 patients who developed AP, ultimately 35 had a mild attack, and 5 patients went on to develop severe AP. Two of the five patients that developed severe pancreatitis needed surgery for necrosectomy, and recovered. Three patients with severe AP developed MODS, which included ARDS, and of these, one patient died during the first week of the attack. One patient developed ARDS without going on to develop MODS.

AP delays neutrophil apoptosis
Neutrophils isolated from patients diagnosed with AP had significant decreases in the number of apoptotic cells after 24 h in vitro incubation compared with control neutrophils incubated for the same time. There were no apoptotic cells found in freshly isolated neutrophils (data not shown). Apoptosis was assessed by propidium iodide DNA staining and confirmed by morphology (Fig. 1 ). nThe study group was further divided into mild and severe, with delays in the severe group significantly greater than the mild (Fig. 1) . Serum from patients with AP reduced significantly the percentage of apoptotic cells when incubated in vitro for 24 h with control, normal neutrophils. However, there was no difference between the mild and severe groups (Fig. 2 ). Apoptosis was assessed by propidium iodide DNA staining and Annexin-V using flow cytometry.



View larger version (65K):
[in this window]
[in a new window]
 
Figure 1. AP induces a delay in spontaneous neutrophil apoptosis. Neutrophils (1x106) were isolated from the systemic circulation of healthy volunteers (n=10) and patients with diagnosed AP (n=40). Neutrophils were cultured in vitro for 24 h and then assessed for apoptosis by propidium iodide DNA staining. AP patients were divided into mild (n=5) and severe (n=35), based on clinical outcome. Neutrophil (1x106/100 µl) was also cytospun and stained to assess morphological features of apoptosis. *P < 0.05 vs. control percent apoptosis. {dagger}P < 0.05 vs. mild percent apoptosis.

 


View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Effects of control and serum on spontaneous neutrophil apoptosis. Neutrophils (1x106) isolated from healthy volunteers (n=3) were incubated with serum from control (n=10) and AP. Apoptosis was assessed by (a) propidium iodide DNA staining using flow cytometry after 24 h and (b) Annexin-V staining (6 h). AP patients were divided into mild (n=5) and severe (n=35), based on clinical outcome. *P < 0.05 vs. control.

 
Neutrophils isolated from the mild (n=27) and severe (n=5) groups not only had delays in spontaneous apoptosis but were also resistant to the effects of Fas ligation (Fig. 3 ), which induces apoptosis in normal resting neutrophils. There was no difference in response between the mild and severe groups (data not shown).



View larger version (14K):
[in this window]
[in a new window]
 
Figure 3. Effects of Fas antibody on neutrophil apoptosis in control and AP patients. Neutrophils (1x106) isolated from healthy volunteers (n=10) and patients with AP (n=32) (mild=27, and severe=5) were incubated with Fas antibody (CH-11, 100 ng/ml) for 24 h. Apoptosis was assessed by propidium iodide DNA binding. Open bar, Cells incubated without Fas antibody; solid bar, cells incubated with Fas antibody. *P < 0.05 vs. control without Fas antibody. {dagger}P < 0.05 vs. control.

 
IL-1ß and GM-CSF were increased in serum isolated from the five severe patients compared with mild and healthy controls (Fig. 4a and b ). Blocking mAbs to IL-1ß or GM-CSF, however, did not prevent the antiapoptotic effects of the serum (data not shown).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 4. Serum IL-1ß and GM-CSF levels in control and AP patients. Serum was collected at the time of neutrophil isolation from control (n=10) and AP (n=40) patients and was stored at -80°C. (a) IL-1ß and (b) GM-CSF were measured by the Quantikine Human Immunoassay Kit in all samples. AP patients were divided into mild (n=5) and severe (n=35), based on clinical outcome. *P < 0.05 vs. control.

 
Caspase expression in neutrophils isolated from AP patients
Densitometry analysis of western blotting demonstrated no difference in neutrophil procaspase 8 expression among control, mild, and severe AP patients (Fig. 5a ). Significant decreases in procaspase 3 were demonstrated between the control and AP groups, with no significant difference between the mild and severe (Fig. 5b) .



View larger version (33K):
[in this window]
[in a new window]
 
Figure 5. Caspase expression in control and AP neutrophils. Total protein was extracted from neutrophils (2x106) after isolation from control (n=10), mild (n=35), and severe AP patients. Equal protein (40 µg) was loaded on an SDS-PAGE gel and transferred onto an Immobilon-P membrane. Equal loading was confirmed by ponceau S solution (2%). (a) Caspase 8 protein was detected using a mouse antihuman polyclonal antibody (1:1000) and secondary HRP-conjugated goat antimouse (GAM) antibody (1:5000). (b) Caspase 3 protein was detected using a mAb (1:1000) and secondary HRP-conjugated GAM antibody (1:1000). Protein was detected using ECL. Densitometry was carried out to assess density of protein and expressed as a percentage of control. AP patients were divided into mild (n=5) and severe (n=35), based on clinical outcome. *P < 0.05 vs. control. Blots represent selection of patients from the control, mild, and severe groups.

 
Resistance to apoptosis was also associated with an increase in GST expression. Densitometry analysis of western blots carried out on 10 controls, 35 mild and 5 severe patients (Fig. 6a ), showed an increased expression of GST in the mild and severe patients compared with controls. There was no alteration in the expression of Mcl-1 among any of the experimental groups (Fig. 6b) .



View larger version (22K):
[in this window]
[in a new window]
 
Figure 6. GST and Mcl-1 expression in control and AP neutrophils. Total protein was extracted from neutrophils (2x106) isolated from control (n=10), mild (n=35), and severe (n=5) AP patients. Equal protein (40 µg) was loaded on an SDS-PAGE gel and transferred onto an Immobilon-P membrane. Equal loading was confirmed by ponceau S solution (2%). (a) GST and (b) Mcl-1 were detected using mouse antihuman mAbs and secondary HRP-conjugated GAM antibody. Densitometry was carried out to assess density of protein and expressed as a percentage of control. AP patients were divided into mild (n=5) and severe (n=35), based on clinical outcome. *P < 0.05 vs. control. Blots represent selection of patients from the control, mild, and severe groups.

 
Serum from five mild and five severe AP patients had no effect on altering the expression of normal neutrophil procaspase 3 expression (data not shown).

Delayed apoptosis is reversed by diethylmaleate (DEM)
DEM, a glutathione-depleting agent, mediates neutrophil apoptosis through direct activation of the caspase cascade (unpublished results). DEM induced significant apoptosis in normal and AP neutrophils (Fig. 7 ).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 7. Effects of DEM on neutrophil apoptosis in control and AP patients. Neutrophils (1x106) from healthy volunteers (n=5) and patients with mild AP (n=20) were incubated with DEM (250 µM) for 24 h. Apoptosis was then assessed by propidium iodide DNA binding. Open bar, Without treatment; solid bar, with DEM. *P < 0.05 vs. control.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
AP is accompanied by destruction and digestion of tissues, causing hypercytokinemia and hyperreactivity of leukocytes and vascular endothelial cells [2 ]. Severe pancreatitis can lead to the development of multiple organ failure, with about one-third of patients dying directly as a result of this in the early phase of an attack [3 ]. Of the five patients with severe pancreatitis, three developed MODS, and one died, supporting previous findings.

Local injury and mortality of AP are, in part, mediated by the neutrophil through the release of reactive oxygen intermediates and proteolytic enzymes [19 ]. Studies in experimental models of AP indicate that pancreatic oxidative stress occurs during an early stage of induction. Scavenger therapy has demonstrated some success, especially when administered before induction [20 ]. Increased lipid peroxidation is increased in human AP in bile and pancreatic tissue [21 ]. Neutrophil infiltration, the source of reactive oxygen intermediates, has been detected in the pancreas as early as 1 h after the induction of experimental AP [6 ]. The depletion of circulating neutrophils has also been demonstrated to decrease the severity of pancreatitis and completely prevents lung injury [7 ]. The resolution of any inflammatory response is, in part, dependent on the induction of neutrophil apoptosis and thus their removal from the inflammatory site. Delays in this apoptotic response may lead to the accumulation of activated neutrophils and increased tissue damage [8 , 22 , 23 ]. This study demonstrates a significant decrease in the number of apoptotic neutrophils after incubation in vitro, when isolated from mild and severe AP patients compared with controls. This indicates a delay in their apoptotic induction. Prolonged neutrophil survival may contribute to the development of MODS in the severe group, but, as yet, this is a small preliminary group of patients, and a larger study will have to be carried out. The development of other inflammatory disorders, such as ARDS and MODS, previously has been associated with delayed rates of neutrophil apoptosis [9 , 10 ].

Serum factors contribute to this delay in apoptosis, however there was no difference in the effect induced by mild and severe serum. Many inflammatory cytokines, including IL-1ß [13 ] and GM-CSF [12 ], have been shown to delay neutrophil apoptosis. These were increased in the serum of the severe group, but other cytokines may also be involved in this effect. This was underlined by the fact that mAbs to IL-1ß and GM-CSF had no effect on inhibiting the antiapoptotic effects of the serum.

Caspase proteases represent a central mechanism mediating apoptosis [15 ]. Fas ligation is an important trigger of this caspase cascade [14 ]. Fas antibodies induce apoptosis in normal neutrophils, however cells isolated from mild and severe groups were resistant to this induction. Resistance to Fas ligation is associated with delayed neutrophil apoptosis in in vivo and in vitro models of inflammation [18 , 24 ]. Neutrophils isolated from the circulation of septic patients demonstrate similar delays in spontaneous apoptosis and are resistant to Fas ligation [10 ]. Cleavage and activation of the initiator caspase 8 and effector caspase 3 are important steps in the cascade, leading to apoptosis of normal neutrophils incubated with Fas antibodies [17 ]. Altered caspase expression has been hypothesized to contribute to differential activation and resistance to apoptosis [25 ]. This study demonstrated no difference in expression of procaspase 8 among the control, mild, and severe groups but a significant decrease in procaspase 3 expression in both AP groups compared with control. This result was unexpected, because decreased procaspase expression would be associated with conversion to the active caspase and induction of apoptosis. Further studies are required to determine if there is a corresponding decrease in mRNA for these caspases. Mechanisms that regulate the expression of these caspases are unknown. This alteration in procaspase 3 was only demonstrated in neutrophils isolated from the study patients and not in normal neutrophils incubated with patient serum. Altered procaspase 3 expression may well be mediated at the level of maturation, but still demonstrates a mechanism for delayed spontaneous and Fas antibody-induced apoptosis. Current studies in our laboratory have now demonstrated that GM-CSF has no effect on procaspase 3 expression in normal neutrophils but does alter the cleavage of procaspase 3 (32 kDa) to its active caspase (17 kDa), thus inhibiting spontaneous and Fas antibody-induced apoptosis.

Bcl-2 and thiols have been shown to regulate the cleavage and activity of the caspases [26 ]. Only one Bcl-2 family member, Mcl-1, is expressed in the neutrophil [27 ]. Lipopolysaccharide (LPS) and GM-CSF have been shown to increase the expression of Mcl-1 at 3 h after stimulation, resulting in delayed apoptosis [27 ]. Despite this observation, there was no increased expression of Mcl-1 in neutrophils isolated from mild or severe AP patients. Glutathione has important antiapoptotic properties, which are mediated through the inhibition of caspase activity [17 , 18 ]. Ethical factors limited the amount of blood collected from the patients, and thus, total intracellular glutathione measurements could not be undertaken. Intracellular GST, which is involved in the synthesis of glutathione [28 ], was measured and was shown to be significantly increased in the mild and severe groups. Neutrophil intracellular reduced glutathione (GSH) is increased by LPS and GM-CSF, possibly as a mechanism to protect against oxidative stress [18 ]. This process may also result in the inhibition of apoptosis through caspase inhibition.

Where increased GSH is associated with resistance to apoptosis, depleting this antioxidant results in the induction of programmed cell death [29 ]. Diethylmaleate induces apoptosis in normal and inflammatory neutrophils [29 ] and in the neutrophils isolated from the mild and severe groups of AP. Previous studies have demonstrated that diethylmaleate increases conversion of procaspase 3 to its active caspase, resulting in the induction of apoptosis (unpublished results). This induction of apoptosis may represent a mechanism by which delayed apoptosis can be reversed, and the resolution of an inappropriate inflammatory response can be triggered.

Understanding how AP leads to the MODS could lead to better detection of patients who are at risk and could then be treated in a more aggressive manner. Severe AP is associated with a significant decrease in neutrophil apoptosis and development of MODS. This delay may be mediated at the level of decreased procaspase 3 expression, which is serum-independent, and secondly, at the level of caspase cleavage to its active protein, which is cytokine-dependent. However, further studies will need to be carried out to clarify these mechanisms and determine the significance of reduced procaspase 3 apoptotic-resistant neutrophils.


    ACKNOWLEDGEMENTS
 
This work is supported by a grant from the Wellcome trust (053761) and in part from the Mater College.


    FOOTNOTES
 
Correspondence: R. William G. Watson, Ph.D., Department of Surgery, University College Dublin, Mater Misericordiae Hospital, 47 Eccles Street, Dublin 7, Ireland. E-mail: research{at}profsurg.iol.ie

Received September 20, 1999; revised January 29, 2000; accepted January 31, 2000.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Aho, H. J., Nevalainen, T. J., Havia, V. T., Heinonen, R. J. (1982) Human acute pancreatitis Microbiol. Immunol. Scand. 90,367-373
  2. Ogawa, M. (1998) Acute pancreatitis and cytokines: "second attack" by septic complication leads to organ failure Pancreas 16,312-315[Medline]
  3. Oleynikov, D., Cook, C., Sellers, B., Mone, M. C., Barton, R. (1998) Decreased mortality from necrotizing pancreatitis Am. J. Surg. 176,648-653[Medline]
  4. Haslett, C., Savill, J. S., Meagher, L. (1989) The neutrophil Curr. Opin. Immunol. 2,10-18[Medline]
  5. Smith, J. A. (1995) Neutrophil, host defense and inflammation: a double-edged sword J. Leukoc. Biol. 56,672-686[Abstract]
  6. Folch, E., Closa, D., Prats, N., Gelpi, E., Rosello-Catafau, J. (1998) Leukotriene generation and neutrophil infiltration after experimental acute pancreatitis Inflammation 22,83-93[Medline]
  7. Bhatia, M., Saluja, A. K., Hofbauer, B., Lee, H. S., Frossard, J. L., Steer, M. L. (1998) The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury Int. J. Pancreat. 24,77-83
  8. Haslett, C. (1996) Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes Clin. Sci. 83,639-648[Medline]
  9. Watson, R. W. G., Rotstein, O. D., Nathens, A. B., Parado, J., Marshall, J. C. (1997) Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement J. Immunol. 158,945-953[Abstract]
  10. Jiminez, M. F., Watson, R. W. G., Parodo, J., Evans, D., Foster, D., Steinberg, M., Rotstein, O. D., Marshall, J. C. (1997) Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome Arch. Surg. 132,1263-1270[Abstract]
  11. Lee, A., Whyte, M. K. B., Haslett, C. (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators J. Leukoc. Biol. 54,283-288[Abstract]
  12. Cox, G., Gauldie, J., Jordana, M. (1992) Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro Am. J. Respir. Cell. Mol. Biol. 7,507-513
  13. Watson, R. W. G., Rotstein, O. D., Parodo, J., Bitar, R., Marshall, J. C. (1998) The IL-1ß-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1ß J. Immunol. 161,957-962[Abstract/Free Full Text]
  14. Nagata, S. (1997) Apoptosis by death factor Cell 88,355-365[Medline]
  15. Villa, P., Kaufmann, S. H., Earnshaw, W. C. (1997) Caspases and caspase inhibitors Trends Biochem Sci 22,388-393
  16. Sanghaui, D. M., Thelan, M., Thornberry, N. A., Casiola-Rosen, L., Rosen, A. (1998) Caspase-mediated proteolysis during apoptosis: insight from apoptotic neutrophils FEBS Lett 422,179-184[Medline]
  17. Watson, R. W. G., O’Neill, A., Brannigan, A., Coffey, R., Marshall, J. C., Brady, H. R., Fitzpatrick, J. M. (1999) Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent FEBS Lett 453,67-71[Medline]
  18. Watson, R. W. G., Rotstein, O. D., Jimenez, M., Parodo, J., Marshall, J. C. (1997) Augmented intracellular glutathione inhibits Fas-triggered apoptosis of activated human neutrophils Blood 89,4175-4181[Abstract/Free Full Text]
  19. Tsai, K., Wang, S. S., Chen, T. S., Kong, C. W., Chang, F. Y., Lee, S. D., Lu, F. J. (1998) Oxidative stress: an important phenomenon with pathogenic significance in the progression of acute pancreatitis Gut 42,850-855[Abstract/Free Full Text]
  20. Gough, D. B., Boyle, B., Joyce, W. P., Delaney, C. P., McGeeney, K. F., Gorey, T. F., Fitzpatrick, J. M. (1990) Free radical inhibition and serial chemiluminescence in evolving experimental pancreatitis Br. J. Surg. 77,1256-1259[Medline]
  21. Schoenberg, M. H., Buchler, M., Pietzyk, C., Uhl, W., Birk, D., Eisele, S., Marzinzig, M., Berger, H. G. (1995) Lipid peroxidation and glutathione metabolism in chronic pancreatitis Pancreas 10,36-43[Medline]
  22. Marshall, J. C., Watson, R. W. G. (1997) Programmed cell death (apoptosis) and the resolution of systemic inflammation Can. J. Surg. 40,169-174[Medline]
  23. Dallegri, F., Ottonello, L. (1997) Tissue injury in neutrophilic inflammation Inflamm. Res. 46,382-391[Medline]
  24. Watson, R. W. G., Rotstein, O. D., Nathens, A. B., Parado, J., Soric, I., Bitar, R., Marshall, J. C. (1997) Impaired apoptotic death signalling in inflammatory lung neutrophils is associated with decreased expression of interleukin one beta converting enzyme family proteases (caspases) Surgery 122,163-171[Medline]
  25. Estrov, Z., Thall, P. F., Talpaz, M., Estey, E. H., Kantarjian, H. M., Andreef, M., Harris, D., Van, Q., Walterscheid, M., Kornblau, S. M. (1998) Caspase 2 and caspase 3 protein levels as a predictors of survival in acute myelogenous leukemia Blood 92,3090-3097[Abstract/Free Full Text]
  26. Mirkovic, N., Voehringer, D. W., Story, M. D., McConkey, D. J., McDonnell, T. J., Meyn, R. E. (1997) Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols Oncogene 15,1461-1470[Medline]
  27. Moulding, D. A., Quayle, J. A., Hart, C. A., Edwards, S. W. (1998) Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival Blood 92,2495-2502[Abstract/Free Full Text]
  28. Anderson, M. E. (1998) Glutathione: an overview of biosynthesis and modulation Chem.-Biol. Interact. 111,1-14
  29. Watson, R. W. G., Rotstein, O. D., Nathens, A. B., Dackiw, A. P. B., Marshall, J. C. (1996) Thiol-mediated redox regulation of neutrophil apoptosis Surgery 120,150-158[Medline]



This article has been cited by other articles:


Home page
BloodHome page
E. J. Molloy, A. J. O'Neill, J. J. Grantham, M. Sheridan-Pereira, J. M. Fitzpatrick, D. W. Webb, and R. W. G. Watson
Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone
Blood, October 1, 2003; 102(7): 2653 - 2659.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. L. Frossard, A. K. Saluja, N. Mach, H. S. Lee, L. Bhagat, A. Hadenque, L. Rubbia-Brandt, G. Dranoff, and M. L. Steer
In vivo evidence for the role of GM-CSF as a mediator in acute pancreatitis-associated lung injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L541 - L548.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M.-J. Hsu, S.-S. Lee, and W.-W. Lin
Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway
J. Leukoc. Biol., July 1, 2002; 72(1): 207 - 216.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Neill, S.
Right arrow Articles by Watson, R. W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Neill, S.
Right arrow Articles by Watson, R. W. G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS